Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

Full speed ahead: Unlock the full potential of your brand tracking

Wednesday 2nd May 2018 10:30 EST / 15:30 GMT / 16:30 CEST

Inizio

How scenario testing helped assess demand for a brand launch in the fragmented NSCLC market

Our client was developing a new drug aimed at first line NSCLC patients. Ahead of its launch they wanted to assess likely uptake in an already fragmented market space led...

Inizio

- PMLiVE

Takeda mulls bid for Irish biopharma Shire

The Japanese pharma firm must make a formal offer by 25 April

- PMLiVE

Hansa Medical poaches Vifor Pharma’s CEO

Søren Tulstrup becomes the Swedish biopharma’s CEO and president

- PMLiVE

David Colpman joins Forendo Pharma’s board

He becomes a non-executive director

- PMLiVE

Six degrees of participation

Exploring the ongoing journey to patient empowerment and examining how pharma can play a part in more participatory models of care

- PMLiVE

Merck KGaA inks deal for Medisafe adherence app

The digital programme will be initially rolled out in Brazil, Russia and Mexico

- PMLiVE

First blood to Roche in Hemlibra patent fight with Shire

The new haemophilia drug does not infringe Baxalta’s patent, rules Tokyo court

- PMLiVE

Lucid Group are on the Lookout for World-Shaking Talent

Lucid Group kick-started the week with its second exchange day in 2018, held in their Macclesfield office. With continued growth from new and existing clients, the need to find and...

Lucid Group Communications Limited

- PMLiVE

Leo Pharma appoints new senior vice president

Rhonda Duffy will be responsible for global supply chain

- PMLiVE

WA Communications expands its practice

Appoints two new team members

- PMLiVE

GSK buys Novartis out of consumer health JV after ditching Pfizer bid

Will pay $13bn for the 36.5% stake owned by the Swiss drug maker

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links